ALKEM LABORATORIES
Quarterly Results Analysis [Sep2024]
ALKEM LABORATORIES Quarterly Results
Consolidated | Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 Audited |
Dec2022 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹3,415 Cr | ₹3,032 Cr | ₹2,936 Cr | ₹3,324 Cr | ₹3,440 Cr | ₹2,968 Cr | ₹2,903 Cr | ₹3,041 Cr |
Expenses | ₹2,662 Cr | ₹2,423 Cr | ₹2,534 Cr | ₹2,616 Cr | ₹2,693 Cr | ₹2,579 Cr | ₹2,549 Cr | ₹2,442 Cr |
Operating Income | ₹753 Cr | ₹609 Cr | ₹402 Cr | ₹708 Cr | ₹747 Cr | ₹389 Cr | ₹353 Cr | ₹599 Cr |
Other Income | ₹134 Cr | ₹120 Cr | ₹88 Cr | ₹94 Cr | ₹63 Cr | ₹66 Cr | ₹69 Cr | ₹45 Cr |
Interest | ₹28 Cr | ₹29 Cr | ₹27 Cr | ₹25 Cr | ₹30 Cr | ₹30 Cr | ₹29 Cr | ₹27 Cr |
Depreciation | ₹79 Cr | ₹80 Cr | ₹83 Cr | ₹70 Cr | ₹74 Cr | ₹72 Cr | ₹78 Cr | ₹78 Cr |
Profit Before Tax | ₹780 Cr | ₹619 Cr | ₹367 Cr | ₹655 Cr | ₹648 Cr | ₹353 Cr | ₹212 Cr | ₹539 Cr |
Profit After Tax | ₹702 Cr | ₹550 Cr | ₹304 Cr | ₹604 Cr | ₹615 Cr | ₹288 Cr | ₹68 Cr | ₹460 Cr |
EPS | ₹57.60 | ₹45.60 | ₹24.56 | ₹49.77 | ₹51.90 | ₹23.98 | ₹5.94 | ₹38.04 |
Industry Peers & Returns | 1W | 1M | 1Y |
ALKEM LABORATORIES | 0.4% | -4.3% | 2.9% |
SUN PHARMACEUTICAL INDUSTRIES | 2.3% | -0.8% | 32.7% |
CIPLA | 0.3% | -2% | 10% |
DR REDDYS LABORATORIES | -1.8% | 2.7% | 12.7% |
ZYDUS LIFESCIENCES | 2% | 1.5% | 38% |
DIVIS LABORATORIES | 3.2% | 1.1% | 51.5% |
MANKIND PHARMA | 0.4% | -7.3% | 16.5% |
TORRENT PHARMACEUTICALS | -1.9% | -6% | 28.4% |
LUPIN | -2% | 0.6% | 48.6% |
ALKEM LABORATORIES Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 12.63 % |
Y-o-Y | -0.74 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Sep2024 | ₹3,415 Cr | 12.63 | |
Jun2024 | ₹3,032 Cr | 3.27 | |
Mar2024 | ₹2,936 Cr | -11.67 | |
Dec2023 | ₹3,324 Cr | -3.38 | |
Sep2023 | ₹3,440 Cr | 15.92 | |
Jun2023 | ₹2,968 Cr | 2.24 | |
Mar2023 | ₹2,903 Cr | -4.55 | |
Dec2022 | ₹3,041 Cr | - |
ALKEM LABORATORIES Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 23.69 % |
Y-o-Y | 0.82 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Sep2024 | ₹753 Cr | 23.69 | |
Jun2024 | ₹609 Cr | 51.41 | |
Mar2024 | ₹402 Cr | -43.19 | |
Dec2023 | ₹708 Cr | -5.24 | |
Sep2023 | ₹747 Cr | 91.87 | |
Jun2023 | ₹389 Cr | 10.17 | |
Mar2023 | ₹353 Cr | -41.03 | |
Dec2022 | ₹599 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 9.81 % |
Y-o-Y | 1.57 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Sep2024 | 22.05% | 9.81 | |
Jun2024 | 20.08% | 46.68 | |
Mar2024 | 13.69% | -35.70 | |
Dec2023 | 21.29% | -1.93 | |
Sep2023 | 21.71% | 65.60 | |
Jun2023 | 13.11% | 7.72 | |
Mar2023 | 12.17% | -38.22 | |
Dec2022 | 19.7% | - |
ALKEM LABORATORIES Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 27.57 % |
Y-o-Y | 14.16 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Sep2024 | ₹702 Cr | 27.57 | |
Jun2024 | ₹550 Cr | 80.71 | |
Mar2024 | ₹304 Cr | -49.61 | |
Dec2023 | ₹604 Cr | -1.73 | |
Sep2023 | ₹615 Cr | 113.64 | |
Jun2023 | ₹288 Cr | 325.25 | |
Mar2023 | ₹68 Cr | -85.29 | |
Dec2022 | ₹460 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 13.28 % |
Y-o-Y | 15.05 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Sep2024 | 20.56 % | 13.28 | |
Jun2024 | 18.15 % | 75.02 | |
Mar2024 | 10.37 % | -42.96 | |
Dec2023 | 18.18 % | 1.73 | |
Sep2023 | 17.87 % | 84.23 | |
Jun2023 | 9.7 % | 316.31 | |
Mar2023 | 2.33 % | -84.60 | |
Dec2022 | 15.13 % | - |
ALKEM LABORATORIES Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 26.32 % |
Y-o-Y | 10.98 % |
Quarters | EPS | % Change | |
---|---|---|---|
Sep2024 | ₹57.6 | 26.32 | |
Jun2024 | ₹45.6 | 85.67 | |
Mar2024 | ₹24.56 | -50.65 | |
Dec2023 | ₹49.77 | -4.10 | |
Sep2023 | ₹51.9 | 116.43 | |
Jun2023 | ₹23.98 | 303.70 | |
Mar2023 | ₹5.94 | -84.38 | |
Dec2022 | ₹38.04 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD